CD38 and neoplasm: The results of the flow cytometry assays showed that all anti-CD38 antibodies bound to cells in various CD38+ tumor cell lines in a concentration-dependent manner; 35G5 and 25B5 exhibited a stronger binding ability (Supplementary Figures 5A–F).